Advances in Research on Neurodegeneration [electronic resource] /

The L-DOPA story revisited. Further surprises to be expected? -- The enigma of cell death in neurodegenerative disorders -- Impaired iron homeostasis in Parkinson’s disease -- The molecular mechanism of dopamine-induced apoptosis: identification and charac te rization of genes that med iate dopamine toxicity -- Glyce raldehyde-3-phosp hate dehydrogenase in neurodegenerat ion and apoptosis signaling -- Import ance of familial Parkinson’s disease and parkinsonism to the understand - ing of nigraI degener at ion in sporadic Parkinson’s disease -- cDNA microarray to study gene expression of dopaminergic neurodegeneration and neuroprotection in MPTP and 6 hydroxydopamine models: implications for idiopathic Parkinson’s disease -- Moni toring neurop rotection and restorative therapies in Parkinson’s disease with PET -- Common properties for prop argylamines of enhancing superoxide dismutase and catalase activities in the dopaminergic system in the rat: implications for the life prolonging effect of ( 2212; )deprenyl -- TV3326, a novel neuro protective dru g with cholinesterase and monoamine oxidase inhibito ry activities for the treatm ent of Alzheimer’s disease -- Neurotoxins induce apoptosis in dopamine neurons: prot ection bei N-propargylamine- l(R)- and (5)-aminoi ndan, rasagi line and TV1022 -- Homocysteine and alcoholism -- Neur orescuing effects of the GAPDH ligand CGP 34668 -- The neuroprotective effects of CGP 34668 in the best in vivo model of Parkinson’s disease, the bilaterally MPTP-treated rhesus monke -- Neurotrophic effects of central nicotinic receptor activation -- Regulation of neuronal cell death and differentiation by NGF and IAP family members -- Insulin-like growth factor- 1 (IGF-1): a neuroprotective trophic factor acting via the Aktinase pathway -- GDF-15/MIC-1 a novel member of the TGF-? superfamily -- Changes in cytokines and neurotrophins in Parkinson’s disease -- Psychiatric complications in Parkinson’s disease -- Dementia with Lewy bodies: prevalance, clinical spectrum and natural history -- Neuronal degeneration and reorganization: a mutual principle in pathological and in healthy interactions of limbic and prefrontal circuits -- Depression in alpha-synucleinopathies: prevalence, pathophysiology and treatment -- The serotonin transporter in Alzheimer’s and Parkinson’s disease -- Immunopathogenic and clinical relevance of antibodies against myelin oligodendrocyte glycoprotein (MOG) in Multiple Sclerosis -- Lessons from studies of antigen-specific T cell responses in Multiple Sclerosis -- Glutamate excitotoxicity — a mechanism for axonal damage and oligodendrocyte death in Multiple Sclerosis? -- Evidence for enhanced neuro-inflammatory processes in neurodegenerative diseases and the action of nitrones as potential therapeutics.

Bibliographic Details

Main Authors:	Riederer, P. editor., Calne, D. B. editor., Horowski, R. editor., Mizuno, Y. editor., Olanow, C. W. editor., Poewe, W. editor., Youdim, M. B. H. editor., SpringerLink (Online service)
Format:	Texto biblioteca
Language:	eng
Published:	Vienna : Springer Vienna : Imprint: Springer, 2000
Subjects:	Medicine., Pharmacology., Neurology., Pathology., Psychiatry., Medicine & Public Health., Pharmacology/Toxicology.,
Online Access:	http://dx.doi.org/10.1007/978-3-7091-6301-6
Tags:	Add Tag No Tags, Be the first to tag this record!